Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Helix BioPharma Total Liabilities (Quarterly): 0.9205M for Oct. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 0.9205M |
| July 31, 2023 | 1.413M |
| April 30, 2023 | 0.4935M |
| January 31, 2023 | 0.7269M |
| October 31, 2022 | 4.163M |
| July 31, 2022 | 2.632M |
| April 30, 2022 | 3.291M |
| January 31, 2022 | 3.946M |
| October 31, 2021 | 4.069M |
| July 31, 2021 | 4.374M |
| April 30, 2021 | 1.395M |
| January 31, 2021 | 0.9661M |
| October 31, 2020 | 1.488M |
| July 31, 2020 | 1.435M |
| April 30, 2020 | 1.162M |
| January 31, 2020 | 1.249M |
| October 31, 2019 | 1.344M |
| July 31, 2019 | 3.210M |
| April 30, 2019 | 2.615M |
| January 31, 2019 | 2.192M |
| October 31, 2018 | 2.615M |
| July 31, 2018 | 2.052M |
| April 30, 2018 | 2.508M |
| January 31, 2018 | 2.020M |
| October 31, 2017 | 1.532M |
| Date | Value |
|---|---|
| July 31, 2017 | 1.768M |
| April 30, 2017 | 2.764M |
| January 31, 2017 | 2.042M |
| October 31, 2016 | 1.745M |
| July 31, 2016 | 0.9914M |
| April 30, 2016 | 1.152M |
| January 31, 2016 | 0.7152M |
| October 31, 2015 | 1.039M |
| July 31, 2015 | 0.7449M |
| April 30, 2015 | 0.9356M |
| January 31, 2015 | 0.9307M |
| October 31, 2014 | 0.717M |
| July 31, 2014 | 0.9552M |
| April 30, 2014 | 0.5933M |
| January 31, 2014 | 0.4606M |
| October 31, 2013 | 0.8386M |
| July 31, 2013 | 0.92M |
| April 30, 2013 | 1.303M |
| January 31, 2013 | 1.274M |
| October 31, 2012 | 1.585M |
| July 31, 2012 | 1.390M |
| April 30, 2012 | 1.922M |
| January 31, 2012 | 5.263M |
| October 31, 2011 | 2.386M |
| July 31, 2011 | 2.377M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4935M
Minimum
Apr 2023
4.374M
Maximum
Jul 2021
2.152M
Average
1.435M
Median
Jul 2020
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.370M |
| Shareholders Equity (Quarterly) | 0.4498M |